Company logo

CI - Cigna Corporation

NYSE -> Healthcare -> Healthcare Plans
Bloomfield, United States
Type: Equity

CI price evolution
CI
(in millions $) 31 Jan 2024 30 Sep 2023 30 Jun 2023 31 Mar 2023
Current assets
Cash $7822 $8497 $9585 $7935
Short term investments $925 $1046 $872 $914
Net receivables $22557 $24003 $23476 $22990
Inventory $5645 $4416 $4514 $4211
Total current assets $37351 $34518 $34711 $32027
Long term investments $17985 $18974 $18967 $19010
Property, plant & equipment $3695 $3924 $3884 $3837
Goodwill & intangible assets $75122 $77134 $77524 $77913
Total noncurrent assets $115410 $115127 $115343 $115949
Total investments $18910 $20020 $19839 $19924
Total assets $152761 $149645 $150054 $147976
Current liabilities
Accounts payable $28368 $26993 $26689 $24969
Deferred revenue
Short long term debt $2775 $3046 $4618 $3418
Total current liabilities $48716 $47059 $47345 $44727
Long term debt $28155 $28094 $28115 $29124
Total noncurrent liabilities $57694 $56820 $57183 $58653
Total debt $30930 $31140 $32733 $32542
Total liabilities $106410 $103879 $104528 $103380
Shareholders' equity
Retained earnings $41652 $40982 $39936 $38841
Other shareholder equity -$1864 -$2119 -$1878 -$1769
Total shareholder equity $46223 $45691 $45445 $44502
(in millions $) 31 Jan 2024 31 Jan 2023 31 Dec 2021 31 Dec 2020
Current assets
Cash $7822 $5924 $5081 $10182
Short term investments $925 $905 $920 $1331
Net receivables $22557 $21961 $20041 $17391
Inventory $5645 $4777 $3722 $3165
Total current assets $37351 $30120 $36134 $27799
Long term investments $17985 $16288 $18438 $23262
Property, plant & equipment $3695 $4149 $3692 $4205
Goodwill & intangible assets $75122 $78303 $79913 $79827
Total noncurrent assets $115410 $113812 $118755 $127652
Total investments $18910 $17193 $19358 $24593
Total assets $152761 $143932 $154889 $155451
Current liabilities
Accounts payable $28368 $7775 $21964 $18825
Deferred revenue
Short long term debt $2775 $2993 $2545 $3374
Total current liabilities $48716 $36190 $43572 $36022
Long term debt $28155 $28100 $31125 $29545
Total noncurrent liabilities $57694 $57752 $64133 $69043
Total debt $30930 $31093 $33670 $32919
Total liabilities $106410 $99060 $107705 $105065
Shareholders' equity
Retained earnings $41652 $37874 $32593 $28575
Other shareholder equity -$1864 -$1075 -$884 -$861
Total shareholder equity $46223 $44872 $47112 $50321
(in millions $) 31 Jan 2024 30 Sep 2023 30 Jun 2023 31 Mar 2023
Revenue
Total revenue $49048 $48586 $46517
Cost of revenue $42566 $42476 $40505
Gross Profit $6482 $6110 $6012
Operating activities
Research & development
Selling, general & administrative $3788 $3434 $3538
Total operating expenses $4242 $3889 $3997
Operating income $2240 $2221 $2015
Income from continuing operations
EBIT $2164 $2197 $1920
Income tax expense $391 $374 $295
Interest expense $365 $363 $358
Net income
Net income $1408 $1460 $1267
Income (for common shares) $1408 $1460 $1267
(in millions $) 31 Dec 2023 31 Dec 2022 31 Jan 2022 31 Dec 2020
Revenue
Total revenue $195265 $180516 $160401
Cost of revenue $170088 $157040 $136194
Gross Profit $25177 $23476 $24207
Operating activities
Research & development
Selling, general & administrative $14822 $13186 $14072
Total operating expenses $16641 $13400 $16054
Operating income $8536 $10076 $8153
Income from continuing operations
EBIT $6751 $9503 $12275
Income tax expense $141 $1607 $2379
Interest expense $1446 $1228 $1438
Net income
Net income $5164 $6668 $8458
Income (for common shares) $5164 $6668 $8458
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Net income $1029 $1408 $1460 $1267
Operating activities
Depreciation $765 $766 $755 $749
Business acquisitions & disposals -$4 -$457 $5 $22
Stock-based compensation
Total cash flows from operations $1467 $2826 $2492 $5028
Investing activities
Capital expenditures -$365 -$403 -$397 -$408
Investments $144 -$439 $14 -$2554
Total cash flows from investing -$440 -$1337 -$414 -$2983
Financing activities
Dividends paid -$358 -$362 -$362 -$368
Sale and purchase of stock -$470 -$570 -$125 -$932
Net borrowings -$286 -$1586 $192 $1402
Total cash flows from financing -$1250 -$2572 -$435 -$37
Effect of exchange rate $14 -$7 $4 $5
Change in cash and equivalents -$209 -$1090 $1647 $2013
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Net income $5164 $6668 $5365 $8458
Operating activities
Depreciation $3035 $2937 $2923 $2802
Business acquisitions & disposals -$434 $4835 -$1894 $5453
Stock-based compensation
Total cash flows from operations $11813 $8656 $7191 $10350
Investing activities
Capital expenditures -$1573 -$1295 -$1154 -$1094
Investments -$2835 -$272 -$660 -$1406
Total cash flows from investing -$5174 $3098 -$3611 $2976
Financing activities
Dividends paid -$1450 -$1384 -$1341
Sale and purchase of stock -$2097 -$7218 -$7416 -$3666
Net borrowings -$278 -$2559 $521 -$4736
Total cash flows from financing -$4294 -$11240 -$8212 -$8533
Effect of exchange rate $16 -$86 -$65 $41
Change in cash and equivalents $2361 $428 -$4697 $4834
Fundamentals
Market cap $106.28B
Enterprise value $129.39B
Shares outstanding 292.50M
Revenue N/A
EBITDA N/A
EBIT N/A
Net Income N/A
Revenue Q/Q N/A
Revenue Y/Y N/A
P/E ratio N/A
EV/Sales N/A
EV/EBITDA N/A
EV/EBIT N/A
P/S ratio N/A
P/B ratio 2.21
Book/Share 164.40
Cash/Share 26.74
EPS N/A
ROA N/A
ROE N/A
Debt/Equity 2.30
Net debt/EBITDA N/A
Current ratio 0.77
Quick ratio 0.65